Accueil>>Signaling Pathways>> PROTAC>>Maleimido-tri(ethylene glycol)-propionic acid

Maleimido-tri(ethylene glycol)-propionic acid

Catalog No.GC60236

L'acide maléimido-tri(éthylène glycol)-propionique est un lieur ADC clivable utilisé dans la synthèse de conjugués anticorps-médicament (ADC). L'acide maléimido-tri(éthylène glycol)-propionique est utilisé pour la préparation de précurseurs d'ADC À base de néolymphostine pour la conjugaison site-spécifique du mutant cystéine trastuzumab-A114C. L'acide maléimido-tri(éthylène glycol)-propionique peut également être utilisé comme lieur PROTAC À base de PEG qui peut être utilisé dans la synthèse des PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

Maleimido-tri(ethylene glycol)-propionic acid Chemical Structure

Cas No.: 518044-40-1

Taille Prix Stock Qté
100mg
278,00 $US
En stock
250mg
464,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Maleimido-tri(ethylene glycol)-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Maleimido-tri(ethylene glycol)-propionic acid is used for the preparation of neolymphostin-based ADC precursors for site-specific cysteine mutant trastuzumab-A114C conjugation[1].

Mal-PEG3-C2-acid can be used to synthesis linker-payload 16 (compound 15) and 20 (compound 18). linker-payload 16 amd 20 is conjugated to DAR1.9 and DAR1.7[1].ADC 23 and 24 are Neolymphostin ADCs that composes of DAG 1.9 and DAG1.7 linked to PIKK inhibitors with linker-payload 16 and 20, respectively[1].ADC24 demonstrates cytotoxic activity against BT474 and N87 cell lines with IC50 of 195 and 202 nM, respectively[1].ADC23 demonstrates cytotoxic activity against BT474 and N87 cell lines with IC50 of 286 and 274 nM, respectively[1].

[1]. Zhou D,et al. Novel PIKK inhibitor antibody-drug conjugates: Synthesis and anti-tumor activity.Bioorg Med Chem Lett. 2019 Apr 1;29(7):943-947.

Avis

Review for Maleimido-tri(ethylene glycol)-propionic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Maleimido-tri(ethylene glycol)-propionic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.